IOSP Stock Analysis: Innospec | NASDAQ
Specialty Chemicals | NASDAQ, USA | Market Cap: 2.014m USD | 12M Return: -6.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 15.9M
EPS Trend: -57.6%
Qual. Beats: 0
Rev. Trend: -96.1%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Innospec Inc. (NASDAQ: IOSP) is a U.S.-based specialty chemicals company headquartered in Englewood, Colorado. Founded in 1938 and formerly known as Octel Corp., the company develops, manufactures, blends, and markets chemical products for customers across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. Its business is organized into three operating segments: Performance Chemicals, Fuel Specialties, and Oilfield Services.
The Fuel Specialties segment supplies additives for diesel, jet, marine, fuel oil, and other fuels used in commercial trucking, aviation, marine engines, power generation, and industrial machinery. The Performance Chemicals segment delivers technology-based solutions into personal care, home care, agrochemical, construction, and mining markets, while the Oilfield Services segment provides chemical solutions for drilling, completion, production, and other oil and gas applications.
Innospec serves a diverse customer base that includes large multinational manufacturers, fuel marketers and retailers, marine operators, plastics and coatings producers, and exploration and production companies. As a specialty chemicals producer within the broader materials sector, the company operates on a business-to-business model, supplying formulated chemical additives and process solutions rather than bulk commodity chemicals, which typically allows for higher value-added pricing tied to technical performance and customer-specific applications.
- Fuel Specialties margins benefit from marine sulfur regulations
- Oilfield Services revenue softens with weaker drilling activity
- Share buybacks accelerate earnings per share growth
| Net Income: 114.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.54 > 1.0 |
| NWC/Revenue: 37.10% < 20% (prev 34.69%; Δ 2.42% < -1%) |
| CFO/TA 0.07 > 3% & CFO 127.6m > Net Income 114.2m |
| Net Debt (-238.5m) to EBITDA (179.0m): -1.33 < 3 |
| Current Ratio: 2.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (24.8m) vs 12m ago -1.03% < -2% |
| Gross Margin: 27.41% > 18% (prev 28.68%; Δ -1.27% > 0.5%) |
| Asset Turnover: 99.62% > 50% (prev 100.6%; Δ -1.02% > 0%) |
| Interest Coverage Ratio: 44.10 > 6 (EBIT TTM 136.7m / Interest Expense TTM 3.10m) |
| A: 0.37 (Total Current Assets 999.1m - Total Current Liabilities 334.8m) / Total Assets 1.82b |
| B: 0.62 (Retained Earnings 1.13b / Total Assets 1.82b) |
| C: 0.08 (EBIT TTM 136.7m / Avg Total Assets 1.80b) |
| D: 2.88 (Book Value of Equity 1.34b / Total Liabilities 467.6m) |
| Altman-Z'' = 7.95 = AAA |
| DSRI: 1.03 (Receivables 354.2m/343.5m, Revenue 1.79b/1.79b) |
| GMI: 1.05 (GM 28.68% / 27.41%) |
| AQI: 0.99 (AQ_t 0.27 / AQ_t-1 0.27) |
| SGI: 1.00 (Revenue 1.79b / 1.79b) |
| TATA: -0.01 (NI 114.2m - CFO 127.6m) / TA 1.82b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 80.81 with a total of 135,658 shares traded. Over the past week, the price has changed by -0.71%, over one month by -0.70%, over three months by +7.92% and over the past year by -6.78%.
Current recommended Stop Loss: 78.20 (which is 3.2% or 1.3 ATR below the current price).
Innospec has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy IOSP.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 99.3 | 22.9% |
P/E Trailing = 17.8537
P/E Forward = 17.1527
P/S = 1.1249
P/B = 1.4894
P/EG = 0.6612
Revenue TTM = 1.79b USD
EBIT TTM = 136.7m USD
EBITDA TTM = 179.0m USD
Long Term Debt = 35.5m USD (estimated: total debt 50.6m - short term 15.1m)
Short Term Debt = 15.1m USD (from shortTermDebt, last quarter)
Debt = 50.6m USD (from shortLongTermDebtTotal, last quarter) (leases 50.6m already included)
Net Debt = -238.5m USD (calculated: Debt 50.6m - CCE 289.1m)
Enterprise Value = 1.78b USD (2.01b + Debt 50.6m - CCE 289.1m)
Interest Coverage Ratio = 44.10 (Ebit TTM 136.7m / Interest Expense TTM 3.10m)
EV/FCF = 23.12x (Enterprise Value 1.78b / FCF TTM 76.8m)
FCF Yield = 4.33% (FCF TTM 76.8m / Enterprise Value 1.78b)
FCF Margin = 4.29% (FCF TTM 76.8m / Revenue TTM 1.79b)
Net Margin = 6.38% (Net Income TTM 114.2m / Revenue TTM 1.79b)
Gross Margin = 27.41% ((Revenue TTM 1.79b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Gross Margin QoQ = 27.25% (prev 27.96%)
Tobins Q-Ratio = 0.98 (Enterprise Value 1.78b / Total Assets 1.82b)
Interest Expense / Debt = 6.13% (Interest Expense 3.10m / Debt 50.6m)
Taxrate = 14.22% (19.0m / 133.6m)
NOPAT = 117.3m (EBIT 136.7m * (1 - 14.22%))
Current Ratio = 2.98 (Total Current Assets 999.1m / Total Current Liabilities 334.8m)
Debt / Equity = 0.04 (Debt 50.6m / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = -1.33 (Net Debt -238.5m / EBITDA 179.0m)
Debt / FCF = -3.11 (Net Debt -238.5m / FCF TTM 76.8m)
Total Stockholder Equity = 1.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.35% (Net Income 114.2m / Total Assets 1.82b)
RoE = 8.68% (Net Income TTM 114.2m / Total Stockholder Equity 1.32b)
RoCE = 10.12% (EBIT 136.7m / Capital Employed (Equity 1.32b + L.T.Debt 35.5m))
RoIC = 8.31% (NOPAT 117.3m / Invested Capital 1.41b)
WACC = 8.86% (E(2.01b)/V(2.06b) * Re(8.95%) + D(50.6m)/V(2.06b) * Rd(6.13%) * (1-Tc(0.14)))
Discount Rate = 8.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -33.33 | Cagr: -0.36%
[DCF] Terminal Value 72.28% ; FCFF base≈79.8m ; Y1≈74.1m ; Y5≈67.1m
[DCF] Fair Price = 49.41 (EV 978.4m - Net Debt -238.5m = Equity 1.22b / Shares 24.6m; r=8.86% [WACC]; 5y FCF grow -9.00% → 2.50% )
EPS Correlation: -57.55 | EPS CAGR: -5.67% | SUE: 0.47 | # QB: 0
Revenue Correlation: -96.11 | Revenue CAGR: -4.62% | SUE: 1.03 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.04 | Chg30d=-0.64% | Revisions=-40% | Analysts=3
EPS next Quarter (2026-09-30): EPS=1.24 | Chg30d=+0.40% | Revisions=-40% | Analysts=3
EPS current Year (2026-12-31): EPS=4.78 | Chg30d=-1.04% | Revisions=-40% | GrowthEPS=-9.3% | GrowthRev=+5.5%
EPS next Year (2027-12-31): EPS=6.07 | Chg30d=-0.60% | Revisions=-40% | GrowthEPS=+27.1% | GrowthRev=+6.2%
[Analyst] Revisions Ratio: -73% (up=0, down=8)